Cargando…

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent

Background. In-stent restenosis (ISR) is the gradual narrowing of the vessel lumen after coronary stent implantation due to the increase in vascular smooth muscle cell proliferation. Vascular endothelial growth factor (VEGF) protein plays an important role in this process. Our aim was to analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagyura, Zsolt, Kiss, Loretta, Hirschberg, Kristóf, Berta, Balázs, Széplaki, Gábor, Lux, Árpád, Szelid, Zsolt, Soós, Pál, Merkely, Béla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412144/ https://www.ncbi.nlm.nih.gov/pubmed/28484288 http://dx.doi.org/10.1155/2017/9548612

Ejemplares similares

High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele
por: Bagyura, Zsolt, et al.
Publicado: (2017)

Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population
por: Kiss, Loretta Zsuzsa, et al.
Publicado: (2018)

Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes
por: Szelid, Zsolt, et al.
Publicado: (2015)

Neutrophil-to-Lymphocyte Ratio Is an Independent Risk Factor for Coronary Artery Disease in Central Obesity
por: Bagyura, Zsolt, et al.
Publicado: (2023)

Level of advanced oxidation protein products is associated with subclinical atherosclerosis
por: Bagyura, Zsolt, et al.
Publicado: (2022)

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis
por: Üveges, Áron, et al.
Publicado: (2019)

Long-term prognostic value of left atrial longitudinal strain in an elderly community-based cohort
por: Zhubi Bakija, Fjolla, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on Early Clinical Outcome and Stent Restenosis after Carotid Artery Stenting
por: Achim, Alexandru, et al.
Publicado: (2022)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
por: Masuda, Shinichiro, et al.
Publicado: (2019)

Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis
por: Canpolat, Uğur, et al.
Publicado: (2016)

Successful removal of entrapped Burr with sheathless guiding during stent rotablation
por: Ruzsa, Zoltán, et al.
Publicado: (2017)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents
por: Yin, Jiasheng, et al.
Publicado: (2017)

A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
por: Ucar, Fatih Mehmet
Publicado: (2016)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
por: Pleva, Leos, et al.
Publicado: (2017)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment
por: Gouveia, Viviane, et al.
Publicado: (2016)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Bare-metal stent thrombosis two decades after stenting
por: Acibuca, Aynur, et al.
Publicado: (2015)

Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF
por: Simon, Judit, et al.
Publicado: (2019)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Hybrid surgery techniques for the treatment of in-stent restenosis after 5 years of femoral artery self-expanding bare-metal stent implantation: A case report
por: Zhou, Jianguo, et al.
Publicado: (2022)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Association of monocyte to high-density lipoprotein ratio with bare-metal stent restenosis in STEMI patients treated with primary PCI
por: Avci, Ilhan Ilker, et al.
Publicado: (2018)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy
por: Boros, András Mihály, et al.
Publicado: (2016)

Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one—a systematic review and meta-analysis
por: Kulyassa, Péter, et al.
Publicado: (2023)

Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
por: Wasser, Katrin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9gf7sg61dstfjepmj9cvv0u9d9